SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.

Subjects

Subjects :

CHRONIC kidney failure
TEAMS in the workplace
DIABETES
PEOPLE with diabetes
GLUCAGON-like peptide-1 agonists
THROMBOPOIETIN receptors

Details

Language :

English

ISSN :

09310509

Volume :

35

Issue :

10

Database :

Complementary Index

Journal :

Nephrology Dialysis Transplantation

Publication Type :

Academic Journal

Accession number :

146347624

Full Text :

https://doi.org/10.1093/ndt/gfz137